Related Experiment Video
Updated: Jun 13, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Prevalence of iron overload in patients with chronic kidney disease on peritoneal dialysis: A scoping review
Abdulqadir J Nashwan1,2, Mohammad T Abuawwad3, Jaber H Jaradat4
1Nursing & Midwifery Research Department Hamad Medical Corporation Doha Qatar.
Insights
Iron overload is a concern for chronic kidney disease (CKD) patients on peritoneal dialysis (PD), though less common now. Treatment with iron chelators is effective but requires careful monitoring for side effects.
Area of Science:
- Nephrology
- Hematology
- Internal Medicine
Background:
- Chronic kidney disease (CKD) patients on peritoneal dialysis (PD) face risks of iron overload.
- Iron overload can negatively impact patient prognosis and overall health.
Purpose of the Study:
- To review the prevalence and implications of iron overload in CKD patients undergoing PD.
- To synthesize current understanding of contributing factors, effects, and treatments for iron overload in this population.
Main Methods:
- A comprehensive literature search was performed across five databases.
- 18 selected papers involving 381 PD patients were analyzed.
Main Results:
- No diagnostic cutoff for iron overload was established.
- Factors include iron supplements and MRI diagnosis; iron overload hinders growth in young patients.
- Adverse effects, particularly cardiac issues, were noted; iron chelators like Deferoxamine and Deferasirox showed efficacy.
- Estimated liver iron overload prevalence in PD patients is 10–28.6%, lower than in hemodialysis (HD) patients (75%).
Conclusions:
- Iron overload is less prevalent in current PD patients due to improved treatments like erythropoiesis-stimulating agents.
- Iron chelation therapy is beneficial but carries risks, requiring vigilant monitoring and intervention.
Background And Aims:
Chronic kidney disease (CKD) patients undergoing peritoneal dialysis (PD) are susceptible to complications, including iron overload, which can significantly impact their prognosis and overall health. This scoping review aimed to study the prevalence and implications of iron overload in CKD patients undergoing PD.
Methods:
A comprehensive search was conducted across five databases, leading to the selection of 18 papers for in-depth analysis. These studies collectively involved 381 PD patients, 60.3% were males.
Results:
No consensus was reached regarding the exact diagnostic cutoff for iron overload. The investigations revealed four main aspects: (1) Seven papers identified various factors contributing to iron overload, emphasizing the role of different iron supplements and magnetic resonance imaging's capability to diagnose iron accumulation in organs; (2) Iron overload in young patients was found to hinder growth; (3) Six studies highlighted the adverse effects of iron overload, with cardiac issues being the most significant; (4) Three studies demonstrated the efficacy of iron-chelating agents, Deferoxamine and Deferasirox, in treating iron overload patients undergoing PD. Overall, the estimated prevalence of liver iron overload in CKD patients on PD ranges from approximately 10% to 28.6%, which is far lower than the prevalence of 75% elegantly shown in HD patients.
Conclusion:
While iron overload was a significant concern for CKD patients undergoing PD in the past, it is less common in the current era due to advancements in treatments, such as erythropoiesis-stimulating agents. Treatment with specific chelation agents has proven beneficial, but there is also a risk of adverse effects, necessitating meticulous monitoring and timely intervention.
Related Concept Videos
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Nephrons
Heart Failure Drugs: Diuretics
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...

